In-utero drug exposure

Why This Topic Matters

Prenatal substance exposure can affect how a newborn or older child is evaluated and documented, and accurate coding depends on the clinical context, age of the patient, and whether symptoms are present. Understanding the article helps users distinguish exposure-related documentation from other newborn observation or obstetric coding scenarios.

Article Sections

1. Initial evaluation of a newborn with suspected prenatal exposure

   Discusses the broad coding approach for a days-old infant evaluated because of suspected exposure documented in the birth history. It outlines the type of coding considerations that apply when symptoms are or are not present.

2. Exposure without symptoms and observation coding

   Covers the general situation in which a newborn is examined for a suspected condition that is not found. It addresses how observation and exposure-related documentation are considered together.

3. Ongoing effects in older infants and children

   Addresses later presentations in which prenatal exposure may be associated with growth, neurologic, or developmental concerns. The section discusses how broader pediatric diagnoses may come into play as the child gets older.

4. Maternal medications during labor and newborn effects

   Explains the general coding issue raised when a mother receives medication during labor and the newborn is adversely affected. It places this scenario in the context of labor and delivery–related diagnoses.